JPS5950364A - 鉄測定用試薬 - Google Patents
鉄測定用試薬Info
- Publication number
- JPS5950364A JPS5950364A JP16145882A JP16145882A JPS5950364A JP S5950364 A JPS5950364 A JP S5950364A JP 16145882 A JP16145882 A JP 16145882A JP 16145882 A JP16145882 A JP 16145882A JP S5950364 A JPS5950364 A JP S5950364A
- Authority
- JP
- Japan
- Prior art keywords
- iron
- reducing agent
- acid
- measured
- coloring
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 title claims abstract description 82
- 229910052742 iron Inorganic materials 0.000 title claims abstract description 41
- 239000003153 chemical reaction reagent Substances 0.000 title claims abstract description 5
- 239000003638 chemical reducing agent Substances 0.000 claims abstract description 20
- 238000004040 coloring Methods 0.000 claims abstract description 7
- 150000003839 salts Chemical class 0.000 claims abstract description 5
- 238000004737 colorimetric analysis Methods 0.000 claims abstract description 3
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 claims 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 abstract description 20
- 229960005070 ascorbic acid Drugs 0.000 abstract description 12
- 210000002966 serum Anatomy 0.000 abstract description 12
- CWERGRDVMFNCDR-UHFFFAOYSA-N thioglycolic acid Chemical compound OC(=O)CS CWERGRDVMFNCDR-UHFFFAOYSA-N 0.000 abstract description 12
- 239000002211 L-ascorbic acid Substances 0.000 abstract description 10
- 235000000069 L-ascorbic acid Nutrition 0.000 abstract description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract description 9
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 abstract description 8
- 239000000872 buffer Substances 0.000 abstract description 6
- 238000010521 absorption reaction Methods 0.000 abstract description 5
- -1 alkali metal salt Chemical class 0.000 abstract description 5
- 238000004458 analytical method Methods 0.000 abstract description 5
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 abstract description 3
- 239000002253 acid Substances 0.000 abstract description 3
- 239000007788 liquid Substances 0.000 abstract description 3
- 235000019333 sodium laurylsulphate Nutrition 0.000 abstract description 3
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 abstract description 2
- 229910052783 alkali metal Inorganic materials 0.000 abstract description 2
- 229910052784 alkaline earth metal Inorganic materials 0.000 abstract description 2
- 150000003863 ammonium salts Chemical class 0.000 abstract description 2
- 239000001632 sodium acetate Substances 0.000 abstract description 2
- 235000017281 sodium acetate Nutrition 0.000 abstract description 2
- HRZFUMHJMZEROT-UHFFFAOYSA-L sodium disulfite Chemical compound [Na+].[Na+].[O-]S(=O)S([O-])(=O)=O HRZFUMHJMZEROT-UHFFFAOYSA-L 0.000 abstract description 2
- 229940001584 sodium metabisulfite Drugs 0.000 abstract description 2
- 235000010262 sodium metabisulphite Nutrition 0.000 abstract description 2
- 239000000463 material Substances 0.000 abstract 1
- 238000000034 method Methods 0.000 description 10
- 239000003086 colorant Substances 0.000 description 9
- 102000008133 Iron-Binding Proteins Human genes 0.000 description 7
- 108010035210 Iron-Binding Proteins Proteins 0.000 description 7
- 239000000243 solution Substances 0.000 description 7
- 239000012581 transferrin Substances 0.000 description 7
- 102000004338 Transferrin Human genes 0.000 description 6
- 108090000901 Transferrin Proteins 0.000 description 6
- 150000002505 iron Chemical class 0.000 description 6
- 238000002835 absorbance Methods 0.000 description 5
- 239000012085 test solution Substances 0.000 description 4
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- ZLNQQNXFFQJAID-UHFFFAOYSA-L magnesium carbonate Chemical compound [Mg+2].[O-]C([O-])=O ZLNQQNXFFQJAID-UHFFFAOYSA-L 0.000 description 3
- 239000001095 magnesium carbonate Substances 0.000 description 3
- 229910000021 magnesium carbonate Inorganic materials 0.000 description 3
- 238000005259 measurement Methods 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- DHDHJYNTEFLIHY-UHFFFAOYSA-N 4,7-diphenyl-1,10-phenanthroline Chemical compound C1=CC=CC=C1C1=CC=NC2=C1C=CC1=C(C=3C=CC=CC=3)C=CN=C21 DHDHJYNTEFLIHY-UHFFFAOYSA-N 0.000 description 2
- ZRALSGWEFCBTJO-UHFFFAOYSA-N Guanidine Chemical compound NC(N)=N ZRALSGWEFCBTJO-UHFFFAOYSA-N 0.000 description 2
- ZMZDMBWJUHKJPS-UHFFFAOYSA-M Thiocyanate anion Chemical compound [S-]C#N ZMZDMBWJUHKJPS-UHFFFAOYSA-M 0.000 description 2
- 208000007502 anemia Diseases 0.000 description 2
- 239000011668 ascorbic acid Substances 0.000 description 2
- 239000013522 chelant Substances 0.000 description 2
- 208000006454 hepatitis Diseases 0.000 description 2
- ZMZDMBWJUHKJPS-UHFFFAOYSA-N hydrogen thiocyanate Natural products SC#N ZMZDMBWJUHKJPS-UHFFFAOYSA-N 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- RWPGFSMJFRPDDP-UHFFFAOYSA-L potassium metabisulfite Chemical compound [K+].[K+].[O-]S(=O)S([O-])(=O)=O RWPGFSMJFRPDDP-UHFFFAOYSA-L 0.000 description 2
- 229940043349 potassium metabisulfite Drugs 0.000 description 2
- 235000010263 potassium metabisulphite Nutrition 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- KMVWNDHKTPHDMT-UHFFFAOYSA-N 2,4,6-tripyridin-2-yl-1,3,5-triazine Chemical compound N1=CC=CC=C1C1=NC(C=2N=CC=CC=2)=NC(C=2N=CC=CC=2)=N1 KMVWNDHKTPHDMT-UHFFFAOYSA-N 0.000 description 1
- SEEZWGFVHCMHJF-UHFFFAOYSA-N 2-nitrosophenol Chemical class OC1=CC=CC=C1N=O SEEZWGFVHCMHJF-UHFFFAOYSA-N 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- 208000032467 Aplastic anaemia Diseases 0.000 description 1
- ROFVEXUMMXZLPA-UHFFFAOYSA-N Bipyridyl Chemical group N1=CC=CC=C1C1=CC=CC=N1 ROFVEXUMMXZLPA-UHFFFAOYSA-N 0.000 description 1
- 201000004569 Blindness Diseases 0.000 description 1
- 206010016654 Fibrosis Diseases 0.000 description 1
- 102000006395 Globulins Human genes 0.000 description 1
- 108010044091 Globulins Proteins 0.000 description 1
- 208000036581 Haemorrhagic anaemia Diseases 0.000 description 1
- 102000001554 Hemoglobins Human genes 0.000 description 1
- 108010054147 Hemoglobins Proteins 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 208000015710 Iron-Deficiency Anemia Diseases 0.000 description 1
- CHJJGSNFBQVOTG-UHFFFAOYSA-N N-methyl-guanidine Natural products CNC(N)=N CHJJGSNFBQVOTG-UHFFFAOYSA-N 0.000 description 1
- 208000031845 Pernicious anaemia Diseases 0.000 description 1
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 1
- 241000209140 Triticum Species 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 208000017733 acquired polycythemia vera Diseases 0.000 description 1
- 231100000354 acute hepatitis Toxicity 0.000 description 1
- 239000003463 adsorbent Substances 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- DXDBGSMRYVGPJM-UHFFFAOYSA-N azinous acid Chemical compound ON.ON DXDBGSMRYVGPJM-UHFFFAOYSA-N 0.000 description 1
- 210000001185 bone marrow Anatomy 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 230000007882 cirrhosis Effects 0.000 description 1
- 208000019425 cirrhosis of liver Diseases 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 238000011981 development test Methods 0.000 description 1
- 230000010339 dilation Effects 0.000 description 1
- SWSQBOPZIKWTGO-UHFFFAOYSA-N dimethylaminoamidine Natural products CN(C)C(N)=N SWSQBOPZIKWTGO-UHFFFAOYSA-N 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- WBZKQQHYRPRKNJ-UHFFFAOYSA-N disulfurous acid Chemical compound OS(=O)S(O)(=O)=O WBZKQQHYRPRKNJ-UHFFFAOYSA-N 0.000 description 1
- 230000005183 environmental health Effects 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- IMBKASBLAKCLEM-UHFFFAOYSA-L ferrous ammonium sulfate (anhydrous) Chemical compound [NH4+].[NH4+].[Fe+2].[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O IMBKASBLAKCLEM-UHFFFAOYSA-L 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 231100000283 hepatitis Toxicity 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000002458 infectious effect Effects 0.000 description 1
- 210000004347 intestinal mucosa Anatomy 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 208000019423 liver disease Diseases 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 208000037244 polycythemia vera Diseases 0.000 description 1
- 159000000001 potassium salts Chemical class 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- BDHFUVZGWQCTTF-UHFFFAOYSA-M sulfonate Chemical compound [O-]S(=O)=O BDHFUVZGWQCTTF-UHFFFAOYSA-M 0.000 description 1
- 125000003396 thiol group Chemical group [H]S* 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/84—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving inorganic compounds or pH
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Hematology (AREA)
- Microbiology (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- Inorganic Chemistry (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP16145882A JPS5950364A (ja) | 1982-09-16 | 1982-09-16 | 鉄測定用試薬 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP16145882A JPS5950364A (ja) | 1982-09-16 | 1982-09-16 | 鉄測定用試薬 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS5950364A true JPS5950364A (ja) | 1984-03-23 |
| JPH033911B2 JPH033911B2 (enrdf_load_stackoverflow) | 1991-01-21 |
Family
ID=15735487
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP16145882A Granted JPS5950364A (ja) | 1982-09-16 | 1982-09-16 | 鉄測定用試薬 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS5950364A (enrdf_load_stackoverflow) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102866124A (zh) * | 2012-09-14 | 2013-01-09 | 天津力神电池股份有限公司 | 一种磷酸铁锂中Fe3+含量的测试方法 |
-
1982
- 1982-09-16 JP JP16145882A patent/JPS5950364A/ja active Granted
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102866124A (zh) * | 2012-09-14 | 2013-01-09 | 天津力神电池股份有限公司 | 一种磷酸铁锂中Fe3+含量的测试方法 |
Also Published As
| Publication number | Publication date |
|---|---|
| JPH033911B2 (enrdf_load_stackoverflow) | 1991-01-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Worwood et al. | Serum ferritin | |
| Goldstein et al. | The urine anion gap: a clinically useful index of ammonium excretion | |
| Six et al. | The influence of iron deficiency on tissue content and toxicity of ingested lead in the rat | |
| Esposito et al. | Labile iron in parenteral iron formulations and its potential for generating plasma nontransferrin‐bound iron in dialysis patients | |
| Bell et al. | Serum ferritin assay and bone-marrow iron stores in patients on maintenance hemodialysis | |
| Morgan | Cadmium and zinc abnormalities in bronchogenic carcinoma | |
| Vittori et al. | Morphologic and functional alterations of erythroid cells induced by long-term ingestion of aluminium | |
| Cavill | Diagnostic methods | |
| JPH05506309A (ja) | 凝固アッセイおよび試薬 | |
| Sorbie et al. | Cobalt excretion test for the assessment of body iron stores | |
| Hamstra et al. | Erythropoiesis in response to blood loss in man. | |
| Larsen et al. | Normal iron absorption determined by means of whole body counting and red cell incorporation of 59Fe | |
| Yuzbasiyan‐Gurkan et al. | Net renal tubular reabsorption of zinc in healthy man and impaired handling in sickle cell anemia | |
| Chapman et al. | Acute and chronic effects of alcohol on iron absorption | |
| Paller | Free radical scavengers in mercuric chloride-induced acute renal failure in the rat | |
| EP0137400B1 (en) | Determination of unsaturated iron-binding capacity | |
| Feinstein et al. | Erythropoietin deficiency causes anemia in nephrotic children with normal kidney function | |
| Przybylowski et al. | Prevalence of iron deficiency in heart and kidney allograft recipients | |
| Rossi et al. | Estimation of ifosfamide/cisplatinum-induced renal toxicity by urinary protein analysis | |
| JPS5950364A (ja) | 鉄測定用試薬 | |
| McGregor et al. | Effect of pH and citrate on binding of iron and gallium by transferrin in serum | |
| JPH0453265B2 (enrdf_load_stackoverflow) | ||
| JP2632989B2 (ja) | 不飽和鉄結合能の測定方法 | |
| EP0143805A4 (en) | IMPROVED REAGENT COMPOSITION AND ANALYSIS FOR DETERMINATION OF CREATININE. | |
| EP0592674B1 (en) | Method of assaying metal present in biological specimen and reagent therefor |